✕
CLOSE
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home.
With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.
Founded: 2006
Industry: Insulin Management
Size: +100 employees
Headquarters: Boston, MA
Website: www.glytec.com
Related Articles
Gov. Kemp: Healthcare Technology Company Scales Up in Metro Atlanta
ATLANTA – Governor Brian P. Kemp today announced that Glytec, a major health tech company, will relocate its headquarters to Cobb County, adding 500 new jobs over the next several years. “Georgia’s skilled workforce and business-friendly approach have fostered success...
KLAS Recognizes Glytec Glucommander® for Advancing Inpatient Glycemic Management
New KLAS First Look report highlights customer-reported improvements in patient safety, insulin dosing accuracy, and hypoglycemia reduction. BOSTON, MA — November 12, 2025 — Glytec, the pioneer and leading provider of AI-powered diabetes and glycemic management for...
Glytec and Parkview Health Expand Diabetes and Glycemic Management Partnership Across Indiana and Ohio
Renewal of 10 facilities, Emergency Department implementation, and two new hospital expansions position Parkview for CMS readiness Boston, MA – October 9, 2025 – Glytec, the leading provider of AI-powered diabetes and glycemic management for hospitals and health...
Patrick Cua: Improving Inpatient Diabetes Care: What CIOs Need to Know
The 10 Most Innovative CEOs Making a Difference in 2025 Why this matters now: Almost 40% of inpatients require insulin therapy8. New CMS eCQMs for severe hypoglycemia and hyperglycemia begin January 1, 2026. You need solutions that improve safety, reduce workload, and...
Glytec Named Top Diabetes Management Platform for 2025
Recognition by Healthcare Tech Outlook underscores Glytec’s leadership in hospital insulin management, clinical outcomes, and enterprise scalability BOSTON, Mass., September 11, 2025 — Glytec, the leading provider of an AI-powered diabetes platform for hospitals and...
Glytec Secures $36 Million Growth Investment to Accelerate AI-Powered Diabetes Technology Platform Innovation
BOSTON, MA – June 17, 2025 – Glytec, the leading provider of an AI-powered technology platform for diabetes and related conditions, today announced it has closed a $36 million growth investment led by Savitr Capital and Hayfin Capital Management. This significant...